Average Co-Inventor Count = 6.76
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agensys, Inc. (15 from 196 patents)
2. Arrowhead Pharmaceuticals, Inc. (14 from 95 patents)
3. Bristol-myers Squibb Compnay (11 from 3,681 patents)
40 patents:
1. 12365899 - RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
2. 12188017 - Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin
3. 11840688 - Compositions and methods for inhibiting gene expression of Hif2alpha
4. 11384355 - Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
5. 11214801 - RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
6. 10927373 - Compositions and methods for inhibiting gene expression of Hif2alpha
7. 10858658 - Compositions and methods for inhibiting gene expression of factor XII
8. 10662427 - Compositions and methods for inhibiting gene expression of LPA
9. 10597657 - RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
10. 10308941 - Compositions and methods for inhibiting gene expression of factor XII
11. 10006025 - Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
12. 9976141 - Compositions and methods for inhibiting gene expression of Hif2alpha
13. 9932586 - Compositions and methods for inhibiting gene expression of LPA
14. 9803205 - Compositions and methods for inhibiting gene expression of factor XII
15. 8951744 - Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers